📊 Score Breakdown
Offering Ability
85
Cash Runway
10
Float Risk
45
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
31%
📉 Score Deterioration
40%
• Score rose 27 points recently (worsening)
💰 Capital Raise
38%
• Active shelf registration ($300M, 58% of market cap)
• Active ATM program with $100M remaining capacity
💹 Market Data
Market Cap$517.98M
Shares Outstanding60.80M
Float35.50M
Cash$236.45M
Debt$33.76M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 49.6% shares (2025Q4 vs prior)
101 institutional holders · 34.52M shares
#1
GordonMD Global Investments LP
4.39M shares
#2
GILEAD SCIENCES, INC.
4.13M shares
#3
Bain Capital Life Sciences Investors, LLC
3.11M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest5.28M
Days to Cover6.2
% of Float14.9%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Dec 31, 2024
EFFECT
EFFECT
Apr 02, 2026
424B5
ATM
Apr 02, 2026
S-3
SHELF
Mar 26, 2026
4
INSIDER TRANSACTION
Mar 17, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for KYTX
📊 KYTX FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 KYTX Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.